Carboplatin versus cisplatin in lung cancer

被引：4

作者：

Einhorn, LH ^{[1
]}

机构：

[1] Indiana Univ, Med Ctr, Indianapolis, IN 46204 USA

来源：

LUNG CANCER | 2005年 / 49卷

关键词：

D O I：

10.1016/S0169-5002(05)80084-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：S32 / S35

页数：4

相关论文

共 21 条

[1]

ALBERTI W, 1995, BRIT MED J, V311, P899

[2] VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL [J].

DEPIERRE, A ;

CHASTANG, C ;

QUOIX, E ;

LEBEAU, B ;

BLANCHON, F ;

PAILLOT, N ;

LEMARIE, E ;

MILLERON, B ;

MORO, D ;

CLAVIER, J ;

HERMAN, D ;

TUCHAIS, E ;

JACOULET, P ;

BRECHOT, JM ;

CORDIER, JF ;

SOLALCELIGNY, P ;

BADRI, N ;

BESENVAL, M .

ANNALS OF ONCOLOGY, 1994, 5 (01) :37-42

[3] EVALUATION OF CISPLATIN INTENSITY IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A PHASE-III STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP [J].

GANDARA, DR ;

CROWLEY, J ;

LIVINGSTON, RB ;

PEREZ, EA ;

TAYLOR, CW ;

WEISS, G ;

NEEFE, JR ;

HUTCHINS, LF ;

ROACH, RW ;

GRUNBERG, SM ;

BRAUN, TJ ;

NATALE, RB ;

BALCERZAK, SP .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :873-878

[4] Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial [J].

Georgoulias, V ;

Papadakis, E ;

Alexopoulos, A ;

Tsiafaki, X ;

Rapti, A ;

Veslemes, M ;

Palamidas, P ;

Vlachonikolis, I .

LANCET, 2001, 357 (9267) :1478-1484

[5]

GEORGOULIAS V, 2002, P AN M AM SOC CLIN, V21, P291

[6] Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer [J].

Hotta, K ;

Matsuo, K ;

Ueoka, H ;

Kiura, K ;

Tabata, M ;

Tanimoto, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3852-3859

[7] Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials [J].

Hotta, K ;

Matsuo, K ;

Ueoka, H ;

Kiura, K ;

Tabata, M ;

Tanimoto, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3860-3867

[8] Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials [J].

Hotta, K ;

Matsuo, K ;

Ueoka, H ;

Kiura, K ;

Tabata, M ;

Tanimoto, M .

ANNALS OF ONCOLOGY, 2004, 15 (12) :1782-1789

[9] A RANDOMIZED STUDY COMPARING A HIGH AND A STANDARD DOSE OF CISPLATIN IN COMBINATION WITH ETOPOSIDE IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CARCINOMA [J].

KLASTERSKY, J ;

SCULIER, JP ;

RAVEZ, P ;

LIBERT, P ;

MICHEL, J ;

VANDERMOTEN, G ;

ROCMANS, P ;

BONDUELLE, Y ;

MAIRESSE, M ;

MICHIELS, T ;

THIRIAUX, J ;

MOMMEN, P ;

DALESIO, O .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) :1780-1786

[10] RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS [J].

LECHEVALIER, T ;

BRISGAND, D ;

DOUILLARD, JY ;

PUJOL, JL ;

ALBEROLA, V ;

MONNIER, A ;

RIVIERE, A ;

LIANES, P ;

CHOMY, P ;

CIGOLARI, S ;

GOTTFRIED, M ;

RUFFIE, P ;

PANIZO, A ;

GASPARD, MH ;

RAVAIOLI, A ;

BESENVAL, M ;

BESSEN, F ;

MARTINEZ, A ;

BERTHAUD, P ;

TURSZ, T .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :360-367